Waters Corporation (BIT:1WAT)

Italy flag Italy · Delayed Price · Currency is EUR
275.80
0.00 (0.00%)
Last updated: May 5, 2026, 9:00 AM CET
Market Cap29.20B +78.3%
Revenue (ttm)3.27B +26.4%
Net Income390.14M -31.6%
EPS5.98 -37.5%
Shares Outn/a
PE Ratio74.83
Forward PE23.07
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1
Open275.80
Previous Close275.80
Day's Range275.80 - 275.80
52-Week Range235.70 - 355.50
Betan/a
RSI63.75
Earnings DateAug 4, 2026

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, p... [Read more]

Industry Laboratory Analytical Instruments
Founded 1958
Employees 7,900
Stock Exchange Borsa Italiana
Ticker Symbol 1WAT

Financial Performance

In 2025, Waters's revenue was $3.17 billion, an increase of 6.99% compared to the previous year's $2.96 billion. Earnings were $642.63 million, an increase of 0.75%.

Financial numbers in USD Financial Statements

News

Waters CEO highlights China as key innovation source in the biopharma market

Waters CEO Udit Batra highlighted China as a global biopharmaceutical powerhouse. He said that innovation has fueled a rapid expansion of contract manufacturers moving into full drug development.

2 days ago - CNBC

Waters raises annual profit forecast as biosciences unit drives growth

Lab equipment maker Waters raised its annual profit ​forecast on Tuesday after beating quarterly estimates, driven by robust demand for ‌drug development tools and the strong performance of its biosci...

2 days ago - Reuters

Waters Earnings Call Transcript: Q1 2026

Strong Q1 performance with double-digit organic growth, robust execution in acquired businesses, and 20% adjusted EPS growth led to raised 2026 revenue and EPS guidance. Integration and synergy realization are ahead of plan, with new product launches and China localization supporting future growth.

2 days ago - Transcripts

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

First Quarter 2026 Highlights Total reported revenue of $1.267 billion exceeded the high end of the guidance range by $56 million, driven by strong outperformance in both organic revenue and the acqui...

2 days ago - PRNewsWire

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

MILFORD, Mass., April 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q1 2026 financial results conference call on Tuesday, May 5, 2026 at 8:30 a.m.

17 days ago - PRNewsWire

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Delivers up to 4x faster chromatographic run times to accelerate decisions across discovery, development, and quality workflows.1,3 Achieves 10x improvement in absolute molar mass and extended sizing,...

23 days ago - PRNewsWire

Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit

Waters Corporation (NYSE:WAT) shares are up on Wednesday as the company announced FDA clearance for its Onclarity HPV Self-Collection Kit, a significant step in expanding access to cervical cancer scr...

4 weeks ago - Benzinga

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

FDA-approved BD Onclarity™ HPV Assay is the most comprehensive screening tool for HPV in the U.S.1,4 with extended genotyping and end-to-end automated lab workflows. At-home self-collection reduces si...

4 weeks ago - PRNewsWire

Waters Prices Offering of Senior Notes

MILFORD, Mass., March 18, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) (the "Company" or "Waters") today announced that it has priced an offering (the "Offering") of $3.5 billion aggregate prin...

7 weeks ago - PRNewsWire

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

News Summary: Reduces standard testing times by 80%.1 Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously invisible to measurement. 2 Operates...

2 months ago - PRNewsWire

Waters Transcript: TD Cowen 46th Annual Health Care Conference

Integration of the BD acquisition is progressing, with a focus on operational precision and cross-team learning. Financial guidance is conservative due to China headwinds, but margin and EPS targets are maintained. Core business growth is supported by strong recurring revenues and new product innovation.

2 months ago - Transcripts

Waters Corporation to Present at the TD Cowen Health Care Conference

MILFORD, Mass., Feb. 23, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.

2 months ago - PRNewsWire

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Headlines: Delivers up to 2× higher sensitivity than stainless steel microflow columns, lowering detection and quantitation limits across high-throughput bioseparations, DMPK, and 'omics applications....

2 months ago - PRNewsWire

Why Is Waters Stock Sinking Monday?

Waters Corporation (NYSE: WAT) stock is trading lower on Monday after the company released fourth-quarter 2025 financial results and issued fiscal 2026 guidance.

3 months ago - Benzinga

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

FRANKLIN LAKES, N.J., Feb. 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences & D...

3 months ago - PRNewsWire

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

Announces appointment of Claire M. Fraser, Ph.D.

3 months ago - PRNewsWire

Waters Earnings Call Transcript: Q4 2025

Delivered strong Q4 and full-year growth, completed BD acquisition, and set 2026 guidance for 5.3% blended revenue growth and 8.9–10.4% adjusted EPS growth. Integration and synergy initiatives are underway, with robust momentum in pharma, chemistry, and recurring revenue.

3 months ago - Transcripts

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

Highlights Fourth Quarter 2025 Sales of $932 million landed at the high-end of reported sales growth guidance range; grew 7% as reported and 6% in constant currency Growth led by high single-digit con...

3 months ago - PRNewsWire

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

Distribution date and closing date for spin-off and merger with Waters Corporation set for February 9, 2026 FRANKLIN LAKES, N.J., Jan. 27, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE...

3 months ago - PRNewsWire

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

Waters Corporation's Q4 2025 Financial Results Conference Call will now be held on Monday,  February 9th, 2026 at 8:30am ET in conjunction with the expected close of the transaction MILFORD, Mass., Ja...

3 months ago - PRNewsWire

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

MILFORD, Mass., Jan. 20, 2026 /PRNewswire/ -- Waters Corporation (NYSE:WAT) will hold its Q4 2025 financial results conference call on Thursday, February 12th, 2026 at 8:00 a.m.

3 months ago - PRNewsWire

Waters Transcript: 44th Annual J.P. Morgan Healthcare Conference

A five-year transformation drove commercial and innovation gains, expanding into high-growth adjacencies and culminating in the acquisition of BD's Bioscience and Diagnostics business. The integration is expected to deliver significant cost and revenue synergies, with a strong financial outlook and continued leadership in innovation and growth.

4 months ago - Transcripts

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

MILFORD, Mass., Dec. 23, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will present at the 44th Annual J.P. Morgan ...

4 months ago - PRNewsWire

Waters Transcript: Jefferies London Healthcare Conference 2025

Instrument replacement cycles and innovation in bioseparations, informatics, and diagnostics are driving strong growth, with new products and software models expanding market share. Integration of BD is on track, and forward-looking initiatives are expected to sustain higher growth rates.

6 months ago - Transcripts

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

MILFORD, Mass. , Nov. 11, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D.

6 months ago - PRNewsWire